GE Healthcare and M+W Group have formed a strategic alliance in emerging markets. The alliance will combine GE Healthcare’s expertise in technologies for biopharmaceutical manufacture with M+W Group’s global capabilities in bio-engineering and construction, to assist countries to become self-sufficient in the manufacture of biologics such as vaccines, insulin and biosimilars. The companies “will offer governments and pharmaceutical companies an integrated, cost-competitive turnkey approac...